title: MDR1/P-glycoprotein function. I. Effect of hypotonicity and inhibitors on rhodamine 123 exclusion.
abstract: The MDR1 protein (P-glycoprotein) is a membrane ATPase whose expression results in resistance to several anti-tumor drugs. It has been proposed that the MDR1 protein, in addition to its pumplike properties, can function as (Gill et al. Cell 71: 23-32, 1992; Altenberg et al. Cancer Res. 54:618-622, 1994) or mediate the activity of (Hardy et al. EMBO J. 14: 68-75, 1995) a hypotonic stress-induced Cl- current. In addition, one study found that drug transport and Cl- channel-associated functions of MRD1 were separable and mutually exclusive and that, when cells were swelled, the MDR1 protein could not transport substrate. This hypothesis was tested in four pairs of isogenic cell lines with MDR1 transfectants expression 8,000-55,000 MDR1 antibody binding sites per cell. Cytoplasmic exclusion of rhodamine 123 was used as an indicator of MDR1 function to measure the effect of hypotonic stress, MDR1 inhibitors, and Cl- channel blockers on MRD1 transport function. It was found that MDR1 activity and its inhibition by cyclosporine A or flufenamic acid were unaffected by hypotonicity alone or in combination with Cl- channel blockers.
authors.affiliation: Division of Research and Testing, Food and Drug Administration, Laurel, Maryland 20708, USA.
authors.forename: J L
authors.initials: JL
authors.lastname: Weaver
authors.forename: L
authors.initials: L
authors.lastname: McKinney
authors.forename: P V
authors.initials: PV
authors.lastname: Schoenlein
authors.forename: S
authors.initials: S
authors.lastname: Goldenberg
authors.forename: M M
authors.initials: MM
authors.lastname: Gottesman
authors.forename: A
authors.initials: A
authors.lastname: Aszalos
mesh_terms: D016475:3T3 Cells; D017878:4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid / Q000494:pharmacology; D012856:4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid / Q000494:pharmacology; D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000502:physiology*; D000818:Animals; D018118:Chloride Channels / Q000037:antagonists & inhibitors*; D016572:Cyclosporine / Q000494:pharmacology; D005439:Flufenamic Acid / Q000494:pharmacology; D006801:Humans; D007038:Hypotonic Solutions / Q000494:pharmacology*; D051379:Mice; D020112:Rhodamine 123; D012235:Rhodamines / Q000493:pharmacokinetics*; D014407:Tumor Cells, Cultured
chemical_list: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D018118:Chloride Channels; D007038:Hypotonic Solutions; D012235:Rhodamines; D020112:Rhodamine 123; D012856:4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid; D005439:Flufenamic Acid; D016572:Cyclosporine; D017878:4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid